Work

A phase II trial of intraperitoneal EGEN-001, an interleukin (IL)-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: A GOG study

Year: 2014

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2014.03.117

Authors: R.D. Alvarez, M. Sill, S.A. Davidson, C. Muller, D.P. Bender, R. DeBernardo, K. Behbakht, W.K. Huh

Institutions: University of Alabama at Birmingham, University of Colorado Denver, University of New Mexico, University of Iowa Hospitals and Clinics, Cleveland Clinic

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2088039845

FWCI:

Cites:

Cited by: 1

Related to: 10